(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.17%) $0.928
(0.31%) $10.87
(0.02%) $0.792
(-0.03%) $92.55
Live Chart Being Loaded With Signals
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States...
Stats | |
---|---|
Today's Volume | 325.00 |
Average Volume | 796.00 |
Market Cap | 624 980 |
EPS | $-0.727 ( 2023-11-13 ) |
Next earnings date | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0642 |
ATR14 | $0.236 (23.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-16 | Wagner Todd R | Sell | 303 107 000 | SERIES A PREFERRED STOCK |
2024-01-16 | Wagner Todd R | Buy | 303 107 | COMMON STOCK |
2024-01-16 | Farrior J Rex Iii | Sell | 13 168 000 | SERIES A PREFERRED STOCK |
2024-01-16 | Farrior J Rex Iii | Buy | 13 168 | COMMON STOCK |
2022-03-21 | Lynch Frederick J | Sell | 8 321 785 | STOCK PURCHASE WARRANTS |
INSIDER POWER |
---|
-99.54 |
Last 90 transactions |
Buy: 833 204 294 | Sell: 379 884 747 |
Volume Correlation
H-CYTE, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
H-CYTE, Inc. Correlation - Currency/Commodity
H-CYTE, Inc. Financials
Annual | 2022 |
Revenue: | $453 460 |
Gross Profit: | $335 859 (74.07 %) |
EPS: | $-49.51 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-105 534 (0.00 %) |
EPS: | $-0.730 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-165 257 (0.00 %) |
EPS: | $-5.83 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $-999.00 (0.00 %) |
EPS: | $-7.78 |
Financial Reports:
No articles found.
H-CYTE, Inc.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators